Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System

Abstract

Assessment of promoter hypermethylation aberrations may facilitate prognostic profiling of lung tumors, but validation in independent data sets is needed to verify these profiles. This system uses material that is abundantly available with linked outcome data and can be used to generate reliable epigenetic determinants.